Evidence map›Paper›PMID 38468555›Full record

ArticlePediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society

Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge.

Fouad El Dana, Sofia Alexandra Garces Narvaez, Nader K El-Mallawany, Jennifer E Agrusa, ZoAnn E Dreyer, Andrea N Marcogliese, Mohamed Tarek Elghetany, Jyotinder N Punia, Chi Young Ok, Keyur P Patel and 3 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fouad El DanaDepartment of Pathology & Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Sofia Alexandra Garces NarvaezDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nader K El-MallawanyDepartment of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Jennifer E AgrusaDepartment of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
ZoAnn E DreyerDepartment of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Andrea N MarcoglieseDepartment of Pathology & Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Mohamed Tarek ElghetanyDepartment of Pathology & Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Jyotinder N PuniaDepartment of Pathology & Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Chi Young OkDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Keyur P PatelDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dolores H Lopez-TerradaDepartment of Pathology & Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Kevin E FisherDepartment of Pathology & Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.ORCID 0000-0002-6179-0937
Choladda V CurryDepartment of Pathology & Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.ORCID 0000-0003-4783-6991

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present 2 diagnostically challenging cases of pediatric/adolescent relapsed/refractory aggressive mature B-cell non-Hodgkin lymphoma (B-NHL) within the spectrum of Burkitt lymphoma and diffuse large B-cell lymphoma and illustrate the different therapeutic regimens that are employed for pediatric and adult cancer centers. Both cases displayed varying-sized lymphoma cells with occasional single prominent nucleoli and heterogeneous BCL2 expression. Cytogenetics revealed complex karyotypes with t(8:14)(q24.2;q32) and

Indexed as

Burkitt LymphomaLymphoma, Large B-Cell, DiffuseProto-Oncogene Proteins c-bcl-2Translocation, GeneticAdolescentBiomarkers, TumorChildChromosomes, Human, Pair 14Chromosomes, Human, Pair 8Diagnosis, DifferentialHumansNeoplasm Recurrence, LocalBCL2 protein, humanBiomarkers, TumorProto-Oncogene Proteins c-bcl-2aggressive b-cell non-Hodgkin lymphomaBCL2B-NHLBurkittDLBCLICCpediatricWHO-HAEM5

Identifiers

PMID38468555
PMCPMC11340240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.